Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Poulter

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Journal of the American Heart Association|July 2, 2018
Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE TrialMerlin C Thomas, Mark Woodward, Qiang Li, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 26, 2024
May Measurement Month 2021: an analysis of blood pressure screening results from ArmeniaParounak Zelveian, Zoya Hakobyan, Heghine Gharibyan, et al.
Diabetologia|May 10, 2020
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE studyKatie Harris, Megumi Oshima, Naveed Sattar, et al.
Diabetes|November 14, 2013
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE studyGordon Lowe, Mark Woodward, Graham Hillis, et al.
Cardiovascular Diabetology|July 29, 2017
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetesKamel Mohammedi, Mark Woodward, Michel Marre, et al.
Journal of Hypertension|August 16, 2019
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension studyCheryl Carcel, Bruce Neal, Suzanne Oparil, et al.
Diabetes Care|May 10, 2014
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trialYoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, et al.
BMJ Open|January 10, 2016
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trialJuuso I Blomster, Mark Woodward, Sophia Zoungas, et al.
Journal of the American College of Cardiology|September 15, 2022
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With DiabetesNelson Wang, Katie Harris, Pavel Hamet, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 26, 2024
May Measurement Month 2021: an analysis of blood pressure screening results from HungaryJános Nemcsik, Dénes Páll, Zsuzsanna Nemes-Nagy, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Journal of the American Heart Association|July 2, 2018
Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE TrialMerlin C Thomas, Mark Woodward, Qiang Li, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 26, 2024
May Measurement Month 2021: an analysis of blood pressure screening results from ArmeniaParounak Zelveian, Zoya Hakobyan, Heghine Gharibyan, et al.
Diabetologia|May 10, 2020
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE studyKatie Harris, Megumi Oshima, Naveed Sattar, et al.
Diabetes|November 14, 2013
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE studyGordon Lowe, Mark Woodward, Graham Hillis, et al.
Cardiovascular Diabetology|July 29, 2017
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetesKamel Mohammedi, Mark Woodward, Michel Marre, et al.
Journal of Hypertension|August 16, 2019
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension studyCheryl Carcel, Bruce Neal, Suzanne Oparil, et al.
Diabetes Care|May 10, 2014
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trialYoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, et al.
BMJ Open|January 10, 2016
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trialJuuso I Blomster, Mark Woodward, Sophia Zoungas, et al.
Journal of the American College of Cardiology|September 15, 2022
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With DiabetesNelson Wang, Katie Harris, Pavel Hamet, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 26, 2024
May Measurement Month 2021: an analysis of blood pressure screening results from HungaryJános Nemcsik, Dénes Páll, Zsuzsanna Nemes-Nagy, et al.
Pageof 18